LEVEL UP
Aguardando manifestação sobre oposição
Marca Mista depositada no INPI em
03/07/2025 por RAPHAEL COSTA,
processo nº 939846845, nas classes 01, 05, 42, 44.
O processo ainda está em andamento no INPI.
| Número do processo | 939846845 |
|---|
| Situação | Aguardando manifestação sobre oposição |
|---|
| Apresentação | Mista |
|---|
| Natureza | Produtos e/ou Serviço |
|---|
| Data do depósito | 03/07/2025 |
|---|
| Data da concessão | — |
|---|
| Vigência até | — |
|---|
| Titular | RAPHAEL COSTA |
|---|
| CNPJ/CPF do titular | 18.542.990/0001-55 |
|---|
| UF · País | DF · BR |
Classes e especificação
Assays and reagents for scientific and research use; diagnostic reagents for scientific use; senolytics.;
Reagents and assays for medical or veterinary use; pharmaceuticals; pharmaceuticals for the treatment and prevention of chronic diseases; pharmaceuticals for the treatment and prevention of age-related disorders and diseases and neurodegenerative disorders and diseases; pharmaceuticals for healthy ageing; pharmaceuticals for the treatment and prevention of disorders and diseases linked to senescent cell accumulation.;
Scientific research and development; scientific research and development in the fields of senolytics, age-related disorders and diseases and neurodegenerative disorders and diseases therapies; services related to scientific research, development and production of pharmaceutical and biopharmaceutical agents and preparations; services in the field of research, development and production of medical, pharmaceutical and biopharmaceutical products; medical- and pharmacological research services; pharmaceutical, biopharmaceutical drug development services; drug discovery services; providing medical and scientific research information in the field of clinical trials.;
Human healthcare services; medical and healthcare services; medical testing for diagnostic or treatment purposes; medical analysis services relating to the treatment of patients; medical testing services relating to the diagnoses and treatment of diseases; consultancy and information services relating to medical, pharmaceutical and biopharmaceutical products; provision of medical treatment for prophylaxis or therapy; medical and healthcare services in the field of personalized medicine; services of personalized medical treatment for prevention of chronic diseases, age-related disorders and diseases and neurodegenerative disorders and diseases; information consultancy and advisory services in relation to the aforesaid.;